혈액 도핑 (Korean Wikipedia)

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Buemi, M; Caccamo, C; Nostro, L; Cavallaro, E; Floccari, F; Grasso, G (Mar 2005). “Brain and cancer: the protective role of erythropoietin”. 《Medicinal Research Reviews》 25 (2): 245–259. doi:10.1002/med.20012. PMID 15389732. S2CID 46380760.
Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.
Haase, VH (Aug 2006). “Hypoxia-inducible factors in the kidney”. 《American Journal of Physiology. Renal Physiology》 291 (2): F271–281. doi:10.1152/ajprenal.00071.2006. PMC 4232221. PMID 16554418.
Joyner, MJ (Jun 2003). “VO2MAX, blood doping, and erythropoietin”. 《British Journal of Sports Medicine》 37 (3): 190–191. doi:10.1136/bjsm.37.3.190. PMC 1724644. PMID 12782539.
Biolo, A; Greferath, R; Siwik, DA; Qin, F; Valsky, E; Fylaktakidou, KC; Pothukanuri, S; Duarte, CD; Schwarz, RP; Lehn, JM; Nicolau, C; Colucci, WS (2009). “Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate”. 《Proc Natl Acad Sci U S A》 106 (6): 1926–1929. Bibcode:2009PNAS..106.1926B. doi:10.1073/pnas.0812381106. PMC 2644140. PMID 19204295.
Görgens, C; Guddat, S; Schänzer, W; Thevis, M (2014). “Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes”. 《Drug Test. Anal.》 6 (11–12): 1102–1107. doi:10.1002/dta.1700. PMID 25070041.
Lam, Geoffrey; Zhao, Sarah; Sandhu, Jasmeet; Yi, Rong; Loganathan, Devan; Morrissey, Barbara (March 2014). “Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP”. 《Drug Testing and Analysis》 6 (3): 268–276. doi:10.1002/dta.1473. ISSN 1942-7611. PMID 23733541.
Gledhill, N (1982). “Blood doping and related issues: A brief review”. 《Med Sci Sports Exerc》 14 (3): 183–189. doi:10.1249/00005768-198203000-00005. PMID 7109883.
Ghaphery, NA (1995). “Performance-enhancing drugs”. 《Orthop Clin North Am》 26 (3): 433–442. doi:10.1016/S0030-5898(20)32008-3. PMID 7609958.
Scott, MG; Kucik, DF; Goodnough, LT; Monk, TG (1997). “Blood substitutes: Evolution and future applications”. 《Clin Chem》 43 (9): 1724–1731. doi:10.1093/clinchem/43.9.1724. PMID 9299967.
Ma, Z; Monk, TG; Goodnough, LT; McClellan, A; Gawryl, M; Clark, T; Moreira, P; Keipert, PE; Scott, MG (1997). “Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests”. 《Clin Chem》 43 (9): 1732–1737. doi:10.1093/clinchem/43.9.1732. PMID 9299968.
Hughes, GS Jr; Antal, EJ; Locker, PK; Francom, SF; Adams, WJ; Jacobs, EE Jr (1996). “Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans”. 《Crit Care Med》 24 (5): 756–764. doi:10.1097/00003246-199605000-00006. PMID 8706450.
Hughes, GS Jr; Yancey, EP; Albrecht, R; Locker, PK; Francom, SF; Orringer, EP; Antal, EJ; Jacobs, EE Jr (1995). “Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans”. 《Clin Pharmacol Ther》 58 (4): 434–443. doi:10.1016/0009-9236(95)90057-8. PMID 7586936. S2CID 19874179.
Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (May 2008). “Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis”. 《JAMA》 299 (19): 2304–2312. doi:10.1001/jama.299.19.jrv80007. PMC 10802128 |pmc= 값 확인 필요 (도움말). PMID 18443023.
Spahn, DR (1999). “Blood substitutes. Artificial oxygen carriers: Perfluorocarbon emulsions”. 《Crit Care》 3 (5): R93–R97. doi:10.1186/cc364. PMC 137239. PMID 11094488.
Riess, JG (2005). “Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery”. 《Artif Cells Blood Substit Immobil Biotechnol》 33 (1): 47–63. doi:10.1081/bio-200046659. PMID 15768565. S2CID 12146605.
Patel, S; Mehra, A (1998). “Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: Tissue oxygenation”. 《ASAIO J》 44 (3): 157–165. doi:10.1097/00002480-199805000-00007. PMID 9617944. S2CID 16079.
Lippi, G.; Franchini, M.; Guidi, G. (2005). “Cobalt chloride administration in athletes: a new perspective in blood doping?”. 《Br J Sports Med》 39 (11): 872–873. doi:10.1136/bjsm.2005.019232. PMC 1725077. PMID 16244201.
Jelkmann, W (2007). “Novel Erythropoietic Agents: A Threat to Sportsmanship”. 《Medician Sportiva》 11 (2): 32–34. doi:10.2478/v10036-007-0007-1.
Kanayaa, K.; Kamitania, T. (2003). “pVHL-independent ubiquitination of HIF1a and its stabilization by cobalt ion”. 《Biochemical and Biophysical Research Communications》 306 (3): 750–755. doi:10.1016/s0006-291x(03)01041-6. PMID 12810083.
Schmidt, Walter; Prommer, Nicole (2005). “The Optimised CO-Rebreathing Method: A New Tool to Determine Total Haemogloblin Mass Routinely”. 《Eur J Appl Physiol》 95 (5–6): 486–495. doi:10.1007/s00421-005-0050-3. PMID 16222540. S2CID 1184048.
Staub, S. 외 (2010). “Analysis of Hemoglobin-Based Oxygen Carriers by CE-UV'Vis and CE-ESI-TOF/MS”. 《Electrophoresis》 31 (7): 1241–1247. doi:10.1002/elps.200900513. PMID 20196028. S2CID 35912270.
Staub, S. 외 (2010). “Blood Doping Detection- A New Analytical Approach with Capillary Electrophoresis”. 《CHIMIA》 64 (12): 886. doi:10.2533/chimia.2010.886.
Pace (January 1947). “The increase in hypoxia tolerance of normal men accompanying the polycythemia induced by transfusion of erythrocytes.”. 《The American Journal of Physiology》 148 (1): 152–163. doi:10.1152/ajplegacy.1947.148.1.152. PMID 20283143.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. 《Ann Pharmacother》 26 (5): 653–659. doi:10.1177/106002809202600510. PMID 1591427. S2CID 44926399.
Urhausen, Axel; Torsten, Albers; Wilfried, Kindermann (2003). “Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic–androgenic steroid abuser”. 《The Journal of Steroid Biochemistry and Molecular Biology》 84 (2–3): 369–375. doi:10.1016/s0960-0760(03)00105-5. PMID 12711025. S2CID 40408423.

go.com (Global: 48^th place; Korean: 173^rd place)

abcnews.go.com

Karlinsky, Neal. "Lance Armstrong Stripped of 7 Tour De France Titles, Banned for Life After Doping Scandal." ABC News. ABC News Network, 22 Oct. 2012. Web. 06 Oct. 2015. [1]

harvard.edu (Global: 18^th place; Korean: 27^th place)

adsabs.harvard.edu

Biolo, A; Greferath, R; Siwik, DA; Qin, F; Valsky, E; Fylaktakidou, KC; Pothukanuri, S; Duarte, CD; Schwarz, RP; Lehn, JM; Nicolau, C; Colucci, WS (2009). “Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate”. 《Proc Natl Acad Sci U S A》 106 (6): 1926–1929. Bibcode:2009PNAS..106.1926B. doi:10.1073/pnas.0812381106. PMC 2644140. PMID 19204295.

la84.org (Global: 4,945^th place; Korean: low place)

library.la84.org

“History of Doping in Sport” (PDF). International Sports Studies, Vol 24, Issue 1. 2002. 2017년 11월 23일에 원본 문서 (PDF)에서 보존된 문서. 2016년 10월 26일에 확인함.

mapinc.org (Global: low place; Korean: low place)

Russell, Ken (1998-09-18). Australia: Troops Get The All-Clear To Dose Up On Energy Drugs. Sydney Morning Herald. Retrieved on 2011-06-01.

mmajunkie.com (Global: 352^nd place; Korean: 8,772^nd place)

“BCAC: Ali Bagautinov tests positive for EPO for UFC 174, suspended one year”. 2014년 7월 10일.

nih.gov (Global: 4^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Buemi, M; Caccamo, C; Nostro, L; Cavallaro, E; Floccari, F; Grasso, G (Mar 2005). “Brain and cancer: the protective role of erythropoietin”. 《Medicinal Research Reviews》 25 (2): 245–259. doi:10.1002/med.20012. PMID 15389732. S2CID 46380760.
Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.
Haase, VH (Aug 2006). “Hypoxia-inducible factors in the kidney”. 《American Journal of Physiology. Renal Physiology》 291 (2): F271–281. doi:10.1152/ajprenal.00071.2006. PMC 4232221. PMID 16554418.
Joyner, MJ (Jun 2003). “VO2MAX, blood doping, and erythropoietin”. 《British Journal of Sports Medicine》 37 (3): 190–191. doi:10.1136/bjsm.37.3.190. PMC 1724644. PMID 12782539.
Biolo, A; Greferath, R; Siwik, DA; Qin, F; Valsky, E; Fylaktakidou, KC; Pothukanuri, S; Duarte, CD; Schwarz, RP; Lehn, JM; Nicolau, C; Colucci, WS (2009). “Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate”. 《Proc Natl Acad Sci U S A》 106 (6): 1926–1929. Bibcode:2009PNAS..106.1926B. doi:10.1073/pnas.0812381106. PMC 2644140. PMID 19204295.
Görgens, C; Guddat, S; Schänzer, W; Thevis, M (2014). “Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes”. 《Drug Test. Anal.》 6 (11–12): 1102–1107. doi:10.1002/dta.1700. PMID 25070041.
Lam, Geoffrey; Zhao, Sarah; Sandhu, Jasmeet; Yi, Rong; Loganathan, Devan; Morrissey, Barbara (March 2014). “Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP”. 《Drug Testing and Analysis》 6 (3): 268–276. doi:10.1002/dta.1473. ISSN 1942-7611. PMID 23733541.
Gledhill, N (1982). “Blood doping and related issues: A brief review”. 《Med Sci Sports Exerc》 14 (3): 183–189. doi:10.1249/00005768-198203000-00005. PMID 7109883.
Ghaphery, NA (1995). “Performance-enhancing drugs”. 《Orthop Clin North Am》 26 (3): 433–442. doi:10.1016/S0030-5898(20)32008-3. PMID 7609958.
Scott, MG; Kucik, DF; Goodnough, LT; Monk, TG (1997). “Blood substitutes: Evolution and future applications”. 《Clin Chem》 43 (9): 1724–1731. doi:10.1093/clinchem/43.9.1724. PMID 9299967.
Ma, Z; Monk, TG; Goodnough, LT; McClellan, A; Gawryl, M; Clark, T; Moreira, P; Keipert, PE; Scott, MG (1997). “Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests”. 《Clin Chem》 43 (9): 1732–1737. doi:10.1093/clinchem/43.9.1732. PMID 9299968.
Lieberthal, W; Fuhro, R; Freedman, JE; Toolan, G; Loscalzo, J; Valeri, CR (1999). “O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin”. 《J Pharmacol Exp Ther》 288 (3): 1278–1287. PMID 10027869.
Hughes, GS Jr; Antal, EJ; Locker, PK; Francom, SF; Adams, WJ; Jacobs, EE Jr (1996). “Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans”. 《Crit Care Med》 24 (5): 756–764. doi:10.1097/00003246-199605000-00006. PMID 8706450.
Hughes, GS Jr; Yancey, EP; Albrecht, R; Locker, PK; Francom, SF; Orringer, EP; Antal, EJ; Jacobs, EE Jr (1995). “Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans”. 《Clin Pharmacol Ther》 58 (4): 434–443. doi:10.1016/0009-9236(95)90057-8. PMID 7586936. S2CID 19874179.
Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (May 2008). “Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis”. 《JAMA》 299 (19): 2304–2312. doi:10.1001/jama.299.19.jrv80007. PMC 10802128 |pmc= 값 확인 필요 (도움말). PMID 18443023.
Spahn, DR (1999). “Blood substitutes. Artificial oxygen carriers: Perfluorocarbon emulsions”. 《Crit Care》 3 (5): R93–R97. doi:10.1186/cc364. PMC 137239. PMID 11094488.
Riess, JG (2005). “Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery”. 《Artif Cells Blood Substit Immobil Biotechnol》 33 (1): 47–63. doi:10.1081/bio-200046659. PMID 15768565. S2CID 12146605.
Patel, S; Mehra, A (1998). “Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: Tissue oxygenation”. 《ASAIO J》 44 (3): 157–165. doi:10.1097/00002480-199805000-00007. PMID 9617944. S2CID 16079.
Lippi, G.; Franchini, M.; Guidi, G. (2005). “Cobalt chloride administration in athletes: a new perspective in blood doping?”. 《Br J Sports Med》 39 (11): 872–873. doi:10.1136/bjsm.2005.019232. PMC 1725077. PMID 16244201.
Kanayaa, K.; Kamitania, T. (2003). “pVHL-independent ubiquitination of HIF1a and its stabilization by cobalt ion”. 《Biochemical and Biophysical Research Communications》 306 (3): 750–755. doi:10.1016/s0006-291x(03)01041-6. PMID 12810083.
Schmidt, Walter; Prommer, Nicole (2005). “The Optimised CO-Rebreathing Method: A New Tool to Determine Total Haemogloblin Mass Routinely”. 《Eur J Appl Physiol》 95 (5–6): 486–495. doi:10.1007/s00421-005-0050-3. PMID 16222540. S2CID 1184048.
Staub, S. 외 (2010). “Analysis of Hemoglobin-Based Oxygen Carriers by CE-UV'Vis and CE-ESI-TOF/MS”. 《Electrophoresis》 31 (7): 1241–1247. doi:10.1002/elps.200900513. PMID 20196028. S2CID 35912270.
Pace (January 1947). “The increase in hypoxia tolerance of normal men accompanying the polycythemia induced by transfusion of erythrocytes.”. 《The American Journal of Physiology》 148 (1): 152–163. doi:10.1152/ajplegacy.1947.148.1.152. PMID 20283143.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. 《Ann Pharmacother》 26 (5): 653–659. doi:10.1177/106002809202600510. PMID 1591427. S2CID 44926399.
Blajchman, M (2002). “Incidence and significance of the bacterial contamination of blood components”. 《Dev Biol (Basel)》 108: 59–67. PMID 12220143.
Urhausen, Axel; Torsten, Albers; Wilfried, Kindermann (2003). “Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic–androgenic steroid abuser”. 《The Journal of Steroid Biochemistry and Molecular Biology》 84 (2–3): 369–375. doi:10.1016/s0960-0760(03)00105-5. PMID 12711025. S2CID 40408423.

pubmed.ncbi.nlm.nih.gov

Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.

semanticscholar.org (Global: 11^th place; Korean: 310^th place)

api.semanticscholar.org

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Buemi, M; Caccamo, C; Nostro, L; Cavallaro, E; Floccari, F; Grasso, G (Mar 2005). “Brain and cancer: the protective role of erythropoietin”. 《Medicinal Research Reviews》 25 (2): 245–259. doi:10.1002/med.20012. PMID 15389732. S2CID 46380760.
Hughes, GS Jr; Yancey, EP; Albrecht, R; Locker, PK; Francom, SF; Orringer, EP; Antal, EJ; Jacobs, EE Jr (1995). “Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans”. 《Clin Pharmacol Ther》 58 (4): 434–443. doi:10.1016/0009-9236(95)90057-8. PMID 7586936. S2CID 19874179.
Riess, JG (2005). “Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery”. 《Artif Cells Blood Substit Immobil Biotechnol》 33 (1): 47–63. doi:10.1081/bio-200046659. PMID 15768565. S2CID 12146605.
Patel, S; Mehra, A (1998). “Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: Tissue oxygenation”. 《ASAIO J》 44 (3): 157–165. doi:10.1097/00002480-199805000-00007. PMID 9617944. S2CID 16079.
Schmidt, Walter; Prommer, Nicole (2005). “The Optimised CO-Rebreathing Method: A New Tool to Determine Total Haemogloblin Mass Routinely”. 《Eur J Appl Physiol》 95 (5–6): 486–495. doi:10.1007/s00421-005-0050-3. PMID 16222540. S2CID 1184048.
Staub, S. 외 (2010). “Analysis of Hemoglobin-Based Oxygen Carriers by CE-UV'Vis and CE-ESI-TOF/MS”. 《Electrophoresis》 31 (7): 1241–1247. doi:10.1002/elps.200900513. PMID 20196028. S2CID 35912270.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. 《Ann Pharmacother》 26 (5): 653–659. doi:10.1177/106002809202600510. PMID 1591427. S2CID 44926399.
Urhausen, Axel; Torsten, Albers; Wilfried, Kindermann (2003). “Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic–androgenic steroid abuser”. 《The Journal of Steroid Biochemistry and Molecular Biology》 84 (2–3): 369–375. doi:10.1016/s0960-0760(03)00105-5. PMID 12711025. S2CID 40408423.

smh.com.au (Global: 132^nd place; Korean: 451^st place)

“Vinokourov questions French lab findings”. The Sydney Morning Herald. 2007년 7월 29일. 2007년 7월 29일에 확인함.

sueddeutsche.de (Global: 226^th place; Korean: 1,448^th place)

“Sportgericht urteilt gegen Pechstein” (독일어). 《sueddeutsche.de》. 2009년 11월 25일.

tsn.ca (Global: 1,325^th place; Korean: low place)

“Russian investigators say Cherepanov was 'doping'”. TSN. Canadian Press. 2008년 12월 29일. 2008년 12월 29일에 확인함.

uzh.ch (Global: 3,633^rd place; Korean: 7,734^th place)

zora.uzh.ch

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.

web.archive.org (Global: 1^st place; Korean: 1^st place)

“History of Doping in Sport” (PDF). International Sports Studies, Vol 24, Issue 1. 2002. 2017년 11월 23일에 원본 문서 (PDF)에서 보존된 문서. 2016년 10월 26일에 확인함.

worldcat.org (Global: 5^th place; Korean: 11^th place)

Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.
Lam, Geoffrey; Zhao, Sarah; Sandhu, Jasmeet; Yi, Rong; Loganathan, Devan; Morrissey, Barbara (March 2014). “Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP”. 《Drug Testing and Analysis》 6 (3): 268–276. doi:10.1002/dta.1473. ISSN 1942-7611. PMID 23733541.

혈액 도핑 (Korean Wikipedia)

archive.org (Global: 6th place; Korean: 18th place)

athleticsintegrity.org (Global: low place; Korean: low place)

bbc.co.uk (Global: 8th place; Korean: 34th place)

news.bbc.co.uk

bleacherreport.com (Global: 262nd place; Korean: 2,096th place)

bloomberg.com (Global: 99th place; Korean: 156th place)

books.google.com (Global: 3rd place; Korean: 9th place)

cyclingnews.com (Global: 949th place; Korean: low place)

autobus.cyclingnews.com

cyclingnews.com

cyclingpost.com (Global: low place; Korean: low place)

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

go.com (Global: 48th place; Korean: 173rd place)

abcnews.go.com

harvard.edu (Global: 18th place; Korean: 27th place)

adsabs.harvard.edu

la84.org (Global: 4,945th place; Korean: low place)

library.la84.org

mapinc.org (Global: low place; Korean: low place)

mmajunkie.com (Global: 352nd place; Korean: 8,772nd place)

nih.gov (Global: 4th place; Korean: 4th place)

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

semanticscholar.org (Global: 11th place; Korean: 310th place)

api.semanticscholar.org

smh.com.au (Global: 132nd place; Korean: 451st place)

sueddeutsche.de (Global: 226th place; Korean: 1,448th place)

tsn.ca (Global: 1,325th place; Korean: low place)

uzh.ch (Global: 3,633rd place; Korean: 7,734th place)

zora.uzh.ch

web.archive.org (Global: 1st place; Korean: 1st place)

worldcat.org (Global: 5th place; Korean: 11th place)

archive.org (Global: 6^th place; Korean: 18^th place)

bbc.co.uk (Global: 8^th place; Korean: 34^th place)

bleacherreport.com (Global: 262^nd place; Korean: 2,096^th place)

bloomberg.com (Global: 99^th place; Korean: 156^th place)

books.google.com (Global: 3^rd place; Korean: 9^th place)

cyclingnews.com (Global: 949^th place; Korean: low place)

doi.org (Global: 2^nd place; Korean: 3^rd place)

go.com (Global: 48^th place; Korean: 173^rd place)

harvard.edu (Global: 18^th place; Korean: 27^th place)

la84.org (Global: 4,945^th place; Korean: low place)

mmajunkie.com (Global: 352^nd place; Korean: 8,772^nd place)

nih.gov (Global: 4^th place; Korean: 4^th place)

semanticscholar.org (Global: 11^th place; Korean: 310^th place)

smh.com.au (Global: 132^nd place; Korean: 451^st place)

sueddeutsche.de (Global: 226^th place; Korean: 1,448^th place)

tsn.ca (Global: 1,325^th place; Korean: low place)

uzh.ch (Global: 3,633^rd place; Korean: 7,734^th place)

web.archive.org (Global: 1^st place; Korean: 1^st place)

worldcat.org (Global: 5^th place; Korean: 11^th place)